The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China.
CHENGDU, China, May 18, 2023 /PRNewswire/ — On May 17, 2023, Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant
Read More